# FDA Inspection 1120939 - Glenmark Pharmaceuticals Ltd - January 17, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-ltd/fa057cb8-def9-4dba-a581-81b9769a1a6d/
Source feed: FDA_Inspections

> FDA Inspection 1120939 for Glenmark Pharmaceuticals Ltd on January 17, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120939
- Company Name: Glenmark Pharmaceuticals Ltd
- Inspection Date: 2020-01-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1075850 - 2018-11-13](https://www.globalkeysolutions.net/api/records/fda_inspections/glenmark-pharmaceuticals-ltd/d33f0248-e9a6-46d9-9c27-2f1175cc61e4/)

Company: https://www.globalkeysolutions.net/companies/glenmark-pharmaceuticals-ltd/71f08626-d60d-4188-a6d7-de55a3b14f3a

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c